Literature DB >> 16895280

Utilization of the office, hospital and emergency department for adult sickle cell patients: a five-year study.

Kenneth Epstein1, Elaine Yuen, Jeff M Riggio, Samir K Ballas, Stephanie M Moleski.   

Abstract

Sickle cell disease (SCD) is a hematological disorder that is manifested primarily by severe pain and chronic organ damage. Little normative data exists on what the usual healthcare utilization is of a population of SCD patients, especially adults. Our study analyzed the office, emergency department (ED) and hospital use data for 142 patients who received care for three consecutive years. Relationships between health service use, patient age, gender and sickle cell phenotype were described. Multivariate analyses studied relationships between demographic and clinical characteristics and levels of office, independent ED and inpatient encounters over a five-year period (1997-2001). We found female patients were older and had less ED and hospital admissions. The 20% highest inpatient utilizers accounted for 54% of the ED total visits, 52% of the ED independent visits, 54% of hospital bed days and 24% of office visits. The ED was a common place for utilization, with a mean of 7.4 visits per patient year, a third of which resulted in a hospital admission. The healthcare utilization of our adult sickle cell population is very complex, with a subset of our patients accounting for a majority of the resources used and female patients living longer but with less ED and hospital admissions.

Entities:  

Mesh:

Year:  2006        PMID: 16895280      PMCID: PMC2569470     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

1.  Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease.

Authors:  Joseph Telfair; Akhlaque Haque; Marc Etienne; Shenghui Tang; Sheryl Strasser
Journal:  Public Health Rep       Date:  2003 Jan-Feb       Impact factor: 2.792

2.  Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2.

Authors:  G J Dover; K D Smith; Y C Chang; S Purvis; A Mays; D A Meyers; C Sheils; G Serjeant
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

Review 3.  Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia.

Authors:  R L Nagel
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

4.  Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia.

Authors:  M H Steinberg; H Hsu; R L Nagel; P F Milner; J G Adams; L Benjamin; S Fryd; P Gillette; J Gilman; O Josifovska
Journal:  Am J Hematol       Date:  1995-03       Impact factor: 10.047

5.  Cost of hospitalizations associated with sickle cell disease in the United States.

Authors:  H Davis; R M Moore; P J Gergen
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

6.  The painful crisis of homozygous sickle cell disease. A study of the risk factors.

Authors:  K F Baum; D T Dunn; G H Maude; G R Serjeant
Journal:  Arch Intern Med       Date:  1987-07

7.  Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises.

Authors:  L J Benjamin; G I Swinson; R L Nagel
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

9.  The costs of children with sickle cell anemia: preparing for managed care.

Authors:  J H Bilenker; W E Weller; T J Shaffer; G J Dover; G F Anderson
Journal:  J Pediatr Hematol Oncol       Date:  1998 Nov-Dec       Impact factor: 1.289

Review 10.  The comprehensiveness care of sickle cell disease.

Authors:  Iheanyi Okpala; Veronica Thomas; Neil Westerdale; Tina Jegede; Kavita Raj; Sadie Daley; Hilda Costello-Binger; Jean Mullen; Collis Rochester-Peart; Sarah Helps; Emense Tulloch; Mary Akpala; Moira Dick; Susan Bewley; Mark Davies; Ian Abbs
Journal:  Eur J Haematol       Date:  2002-03       Impact factor: 2.997

  10 in total
  17 in total

1.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

Review 2.  Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Authors:  Rakhi P Naik; Michael B Streiff; Sophie Lanzkron
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

3.  Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project.

Authors:  Paula Tanabe; Christopher Reddin; Victoria L Thornton; Knox H Todd; Ted Wun; John S Lyons
Journal:  Acad Emerg Med       Date:  2010-08       Impact factor: 3.451

4.  Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie
Journal:  J Pain Symptom Manage       Date:  2014-03-15       Impact factor: 3.612

5.  Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Authors:  Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

6.  The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.

Authors:  Sophie Lanzkron; C Patrick Carroll; Carlton Haywood
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

7.  Sickle cell disease in California: sociodemographic predictors of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Rachna Khanna; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

8.  A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Authors:  E Pizzo; A A Laverty; K J Phekoo; G AlJuburi; S A Green; D Bell; A Majeed
Journal:  J Public Health (Oxf)       Date:  2014-05-05       Impact factor: 2.341

9.  Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.

Authors:  Tiffany Yu; Timothy Campbell; Isabella Ciuffetelli; Carlton Haywood; Christopher Patrick Carroll; Linda Resar; John J Strouse; Sophie Lanzkron
Journal:  South Med J       Date:  2016-09       Impact factor: 0.954

10.  Health-related stigma in young adults with sickle cell disease.

Authors:  Coretta M Jenerette; Cheryl Brewer
Journal:  J Natl Med Assoc       Date:  2010-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.